Accelerate Diagnostics, Inc. AXDX NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score

18/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Accelerate Diagnostics, Inc. (AXDX) .

本頁證實的標準:

VALUE (0/100, 未通過) — 綜合估值評分低於60/100的通過門檻。

SharesGrow 綜合評分： 17/100 其中 0/7 項標準通過。

SharesGrow 7-Criteria Score

18/100

SG Score

View full scorecard →

—

價值

N/A

No coverage

✗

未來

20/100

Analyst consensus

→ Forecast

✗

過去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

護城河

29/100

→ Income

成長

48/100

→ Income

✗

收入

10/100

→ Income

估值概覽 — AXDX

估值倍數

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.07

EV/EBITDA0.0

每股數據

EPS (TTM)$-2.15

每股帳面價值$0.00

每股營收$0.50

每股自由現金流$0.00

收益率與內在價值

盈利收益率N/A

股息收益率0.00%

EPS：實際 vs 預期

P/E Ratio & Earnings Yield

每股盈餘 (EPS) 歷史

Year	EPS（稀釋）	營收	淨利潤	淨利潤率
2015	$-10.11	$147K	$-45.5M	-30951%
2016	$-12.94	$246K	$-66.37M	-26981.3%
2017	$-11.63	$4.18M	$-62.88M	-1505.4%
2018	$-16.21	$5.67M	$-88.33M	-1557.8%
2019	$-15.47	$9.3M	$-84.31M	-906.8%
2020	$-13.96	$11.17M	$-78.21M	-700.5%
2021	$-12.59	$11.78M	$-77.7M	-659.5%
2022	$-7.61	$12.75M	$-62.49M	-490.1%
2023	$-4.94	$12.06M	$-61.62M	-511%
2024	$-2.15	$11.7M	$-50.05M	-427.8%